Report Detail

Pharma & Healthcare Muscle Spasticity - Pipeline Review, H2 2019

  • RnM3868724
  • |
  • 16 January, 2020
  • |
  • Global
  • |
  • 110 Pages
  • |
  • Global Markets Direct
  • |
  • Pharma & Healthcare

Muscle Spasticity - Pipeline Review, H2 2019

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Muscle Spasticity - Pipeline Review, H2 2019, provides an overview of the Muscle Spasticity (Central Nervous System) pipeline landscape.

Spasticity is a condition in which certain muscles are continuously contracted. Symptoms include muscle tightness, joint stiffness, involuntary jerky movements, exaggeration of reflexes, unusual posture, abnormal positioning of fingers, wrists, arms, or shoulders and muscle spasms. Treatment includes relieving the signs and symptoms of spasticity and reducing the pain and frequency of muscle contractions.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Muscle Spasticity - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Muscle Spasticity (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Muscle Spasticity (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Muscle Spasticity and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 5, 4, 5, 5 and 2 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Muscle Spasticity (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Muscle Spasticity (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Muscle Spasticity (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Muscle Spasticity (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Muscle Spasticity (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Muscle Spasticity (Central Nervous System)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Muscle Spasticity (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Muscle Spasticity (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.


Table of Contents

    List of Tables

      List of Figures

        Introduction

          Global Markets Direct Report Coverage

            Muscle Spasticity - Overview

              Muscle Spasticity - Therapeutics Development

                Pipeline Overview

                  Pipeline by Companies

                    Pipeline by Universities/Institutes

                      Products under Development by Companies

                        Products under Development by Universities/Institutes

                          Muscle Spasticity - Therapeutics Assessment

                            Assessment by Target

                              Assessment by Mechanism of Action

                                Assessment by Route of Administration

                                  Assessment by Molecule Type

                                    Muscle Spasticity - Companies Involved in Therapeutics Development

                                      Allaysis LLC

                                        Axim Biotechnologies Inc

                                          CytoDel Inc

                                            Ethicann Pharmaceuticals Inc

                                              Genochem SAS

                                                GW Pharmaceuticals Plc

                                                  H. Lundbeck AS

                                                    Harvest One Cannabis Inc

                                                      Ipsen SA

                                                        Medytox Inc

                                                          Merz Pharma GmbH & Co KgaA

                                                            OBI Pharma Inc

                                                              Osmotica Pharmaceutical Corp

                                                                Revance Therapeutics Inc

                                                                  Sanochemia Pharmazeutika AG

                                                                    Sun Pharma Advanced Research Company Ltd

                                                                      Vitality Biopharma Inc

                                                                        Muscle Spasticity - Drug Profiles

                                                                          Muscle Spasticity - Dormant Projects

                                                                            Muscle Spasticity - Discontinued Products

                                                                              Muscle Spasticity - Product Development Milestones

                                                                                Appendix

                                                                                Summary:
                                                                                Get latest Market Research Reports on Muscle Spasticity. Industry analysis & Market Report on Muscle Spasticity is a syndicated market report, published as Muscle Spasticity - Pipeline Review, H2 2019. It is complete Research Study and Industry Analysis of Muscle Spasticity market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                                                                                Last updated on

                                                                                REPORT YOU MIGHT BE INTERESTED

                                                                                Purchase this Report

                                                                                $2,000.00
                                                                                $4,000.00
                                                                                $6,000.00
                                                                                1,584.00
                                                                                3,168.00
                                                                                4,752.00
                                                                                1,848.00
                                                                                3,696.00
                                                                                5,544.00
                                                                                302,580.00
                                                                                605,160.00
                                                                                907,740.00
                                                                                166,740.00
                                                                                333,480.00
                                                                                500,220.00
                                                                                Credit card Logo

                                                                                Related Reports


                                                                                Reason to Buy

                                                                                Request for Sample of this report